4
Changes in Ownership
Apnimed, Inc. Filed Acc 0001193125-26-330505
Options or other derivatives
- Chief Executive Officer acquired 1,478,238 shares (grant or award)
- Chief Executive Officer returned 1,369,322 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lind Kevin Robert Chief Executive Officer | 2026-08-03 | Returned to the company · Stock Option (Right to Buy) | −74,128 | 0 | D: show line 1 in the form | ||
| Lind Kevin Robert Chief Executive Officer | 2026-08-03 | Grant or award · Stock Option (Right to Buy) | +74,128 | 74,128 | D: show line 2 in the form | ||
| Lind Kevin Robert Chief Executive Officer | 2026-08-03 | Returned to the company · Stock Option (Right to Buy) | −1,186,278 | 0 | D: show line 3 in the form | ||
| Lind Kevin Robert Chief Executive Officer | 2026-08-03 | Grant or award · Stock Option (Right to Buy) | +1,186,278 | 1,186,278 | D: show line 4 in the form | ||
| Lind Kevin Robert Chief Executive Officer | 2026-07-30 | Grant or award · Stock Option (Right to Buy) | +108,916 | 108,916 | D: show line 5 in the form | ||
| Lind Kevin Robert Chief Executive Officer | 2026-08-03 | Returned to the company · Stock Option (Right to Buy) | −108,916 | 0 | D: show line 6 in the form | ||
| Lind Kevin Robert Chief Executive Officer | 2026-08-03 | Grant or award · Stock Option (Right to Buy) | +108,916 | 108,916 | D: show line 7 in the form |
Loading xslF345X06/ownership.xml…